Investor Relations PRESS RELEASES Sep 14, 2021 Epizyme Announces Data from TAZVERIK® (Tazemetostat) Clinical Programs to be Presented During Poster Sessions at 2021 ESMO Virtual Congress Aug 20, 2021 Epizyme Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) View all press releases » EVENTS & PRESENTATIONS There are no events scheduled at this time. May 6, 2021 Corporate Presentation, May 2021 View all events & presentations »
